Immunity and protection of SARS-CoV-2DNA and protein vaccines
A DNA vaccine against SARS-CoV-2 virus infection in a subject is provided, which comprises a codon optimized polynucleotide sequence encoding a polypeptide of the SARS-CoV-2 virus. The invention also provides a vaccine combination for resisting SARS-CoV-2 virus infection, and the vaccine combination...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
22.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | A DNA vaccine against SARS-CoV-2 virus infection in a subject is provided, which comprises a codon optimized polynucleotide sequence encoding a polypeptide of the SARS-CoV-2 virus. The invention also provides a vaccine combination for resisting SARS-CoV-2 virus infection, and the vaccine combination comprises the DNA vaccine and an antigen peptide vaccine. In the NHP research, the vaccine composition can endow comprehensive protection against SARS-CoV-2 virus infection.
提供了在受试者中抗SARS-CoV-2病毒感染的DNA疫苗,其包含编码SARS-CoV-2病毒的多肽的经密码子优化的多核苷酸序列。还提供了抗SARS-CoV-2病毒感染的疫苗组合,其包含所述DNA疫苗和抗原肽疫苗。在NHP研究中,该疫苗组合能够赋予抗SARS-CoV-2病毒感染的全面保护。 |
---|---|
Bibliography: | Application Number: CN202180078930 |